...of Spring Bank Pharmaceuticals Inc., which reverse-merged with F-star Therapeutics Inc. (NASDAQ:FSTX).Indapta Therapeutics Inc. hired former Five Prime Therapeutics Inc....

...with positive efficacy data for Five Prime’s bemarituzumab.Shares of Five Prime Therapeutics Inc....
...ORR) to prespecified statistical significance over chemotherapy alone. Five Prime...
...– Fibroblast growth factor receptor 2b isoform Lauren Martz Five Prime Therapeutics Inc. Zai...

...targeted cancer therapies to which Zai holds regional rights. They include FGFR2b program bemarituzumab from Five Prime Therapeutics Inc....

...hired Lyndah Dreiling as SVP, clinical development. She was VP, head of clinical development at Five Prime Therapeutics Inc....

...governance chair and therapeutic area head for oncology at GlaxoSmithKline plc (LSE:GSK; NYSE:GSK). Cancer company Five Prime Therapeutics Inc....
...CEO of Arianne Clinical Research Inc. Robin Sawka, BioCentury Staff PTC Therapeutics Inc. uniQure N.V. Sangamo BioSciences Inc. TCR2 Therapeutics Inc. Five Prime Therapeutics Inc. Evelo...

...development of Perjeta pertuzumab, Avastin bevacizumab and Tecentriq atezolizumab. Irving was EVP and CSO at Five Prime Therapeutics Inc....

...Cancer company Five Prime Therapeutics Inc. (NASDAQ:FPRX) said founder Lewis “Rusty” Williams will step down from the board to...
...Therapeutics Inc. , a cell therapy company he co-founded this year. Williams was CEO of Five Prime...
...global service organization at Illumina Inc. (NASDAQ:ILMN). Hongjiang Li and Elizabeth S. Eaton, Staff Writers Rubius Therapeutics Inc. Five Prime Therapeutics Inc. Replimune...

...is the managing director of biotech investment firm Woodside Way Ventures and was CMO of Five Prime Therapeutics Inc....

...China) unit of Novartis AG (NYSE:NVS; SIX:NOVN). Aron Knickerbocker has stepped down as CEO of Five Prime Therapeutics Inc....
...Inc. Black Diamond Therapeutics Inc. Oyster Point Pharma Inc. Enyo Pharma S.A. Curis Inc. X4 Pharmaceuticals Inc. Nimbus Therapeutics LLC Canbridge Pharmaceuticals Inc. Five Prime Therapeutics Inc....

...potential in gastric cancer. Bemarituzumab (FPA144), the compound on which its Greater China deal with Five Prime Therapeutics Inc....